XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Schedule of Reconciliation of Common Stock Outstanding
The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September 30, 2024 and the twelve months ended December 31, 2023:
NINE MONTHS ENDED SEPTEMBER 30, 2024TWELVE MONTHS ENDED DECEMBER 31, 2023
Balance, beginning of period380,964,433 380,589,894 
Issuance of common stock8,623 8,627 
Conversion of OP units to common stock194,767 190,544 
Shares Repurchased(25,735,088)— 
Non-vested share-based awards, net of withheld shares and forfeitures401,648 175,368 
Balance, end of period355,834,383 380,964,433 
Schedule of Earnings (Loss) per Share
The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September 30, 2024, and 2023.
THREE MONTHS ENDED SEPTEMBER 30,NINE MONTHS ENDED SEPTEMBER 30,
Dollars in thousands, except per share data2024202320242023
Weighted average common shares outstanding
Weighted average common shares outstanding360,981,496 380,857,560 372,230,619 380,828,004 
Non-vested shares(2,021,666)(1,932,221)(1,976,421)(1,941,897)
Weighted average common shares outstanding - basic358,959,830 378,925,339 370,254,198 378,886,107 
Weighted average common shares outstanding - basic358,959,830 378,925,339 370,254,198 378,886,107 
Dilutive effect of OP Units— — — — 
Weighted average common shares outstanding - diluted358,959,830 378,925,339 370,254,198 378,886,107 
Net loss$(94,535)$(68,604)$(555,692)$(240,408)
Income allocated to participating securities(560)(636)(2,452)(1,868)
Loss attributable to non-controlling interest1,512 760 8,053 2,680 
Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units(549)(29)(2,560)(122)
Net loss applicable to common stockholders - basic$(94,132)$(68,509)$(552,651)$(239,718)
Basic earnings per common share - net loss$(0.26)$(0.18)$(1.49)$(0.63)
Diluted earnings per common share - net loss$(0.26)$(0.18)$(1.49)$(0.63)
Schedule of Stock Options, Valuation Assumptions The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair value of $19.10 for the relative TSR component for the February 2024 grant using the following assumptions:
Volatility28.0 %
Dividend assumptionAccrued
Expected term 3 years
Risk-free rate4.44 %
Stock price (per share)$15.22
The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair value of $9.62 for the relative TSR component for the February 2024 grant using the following assumptions:
Volatility28.0 %
Dividend assumptionAccrued
Expected term 3 years
Risk-free rate4.44 %
Stock price (per share)$15.22
Schedule of the Activity Under the Incentive Plan and RSU Activity
The following table represents the summary of non-vested share-based awards under the Incentive Plan for the three and nine months ended September 30, 2024 and 2023:
THREE MONTHS ENDED SEPTEMBER 30,NINE MONTHS ENDED SEPTEMBER 30,
 2024202320242023
Share-based awards, beginning of period4,085,059 2,923,018 2,615,562 2,090,060 
Granted 1
— — 1,611,578 1,118,537 
Vested(9,730)(11,664)(84,804)(188,070)
Change in awards based on performance assessment— (126,418)(47,202)(205,668)
Forfeited— — (19,805)(29,923)
Share-based awards, end of period4,075,329 2,784,936 4,075,329 2,784,936 
1LTIP-C units are issued at the maximum possible value of the award and are reflected as such in this table until the performance conditions have been satisfied and the exact number of awards are determinable.
Schedule of Unrecognized Compensation Cost, Nonvested Awards
The following table represents expected amortization of the Company's non-vested awards issued as of September 30, 2024:
Dollars in millionsFUTURE AMORTIZATION
of non-vested shares
2024$3.6 
202512.1 
20269.2 
20275.0 
2028 and thereafter2.7 
Total$32.6